CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBF) saw a significant decrease in short interest in August. As of August 31st, there was short interest totalling 1,027,400 shares, a decrease of 11.2% from the August 15th total of 1,157,000 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 10,274.0 days.

CanSino Biologics Stock Performance

CASBF stock remained flat at C$2.52 during mid-day trading on Wednesday. 10 shares of the company’s stock were exchanged, compared to its average volume of 1,593. CanSino Biologics has a 52 week low of C$1.86 and a 52 week high of C$3.55. The stock has a 50-day moving average of C$2.26 and a two-hundred day moving average of C$2.27.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.